Prolactin, TNF alpha and nitric oxide expression in nitroso-N-methylurea-induced-mammary tumours

Journal of Carcinogenesis

Volumn 6, Issue , 2007, Pages

  Vegh, Irene ^a   de Salamanca, Rafael Enríquez ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GOSERELIN; METHYLUREA; METOCLOPRAMIDE; NITRIC OXIDE; PROLACTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOMATION; BODY WEIGHT; BOLUS INJECTION; BREAST ADENOCARCINOMA; BREAST TUMOR; CANCER INCIDENCE; CANCER INHIBITION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL STUDY; FEMALE; FLOW CYTOMETRY; IMMUNOASSAY; NONHUMAN; PLOIDY; PROGNOSIS; PROTEIN EXPRESSION; RAT; TISSUE HOMOGENATE; WISTAR RAT;

EID: 38849131269     PISSN: None     EISSN: 14773163     Source Type: Journal    
DOI: 10.1186/1477-3163-6-18     Document Type: Article

References (38)

1. Gullino PM Pettigrew HM Grantham FH N-nitrosomethylurea as mammary gland carcinogen in rats J Natl Cancer Inst 1975, 54:401-414 1113323
2. Russo J Gusterson BA Rogers AE Russo IH Wellings SR van Zwieten MJ Comparative study of human and rat mammary tumorigenesis Lab Invest 1990, 62:244-278 2107367
3. Martin G Davio C Rivera E Melito G Cricco G Andrade N Caro D Bergoc R Hormone dependence of mammary tumors induced in rats by intraperitoneal NMU injection Cancer Invest 1997, 15:8-17 9028385
4. Curtis JR The role of 7, 12 DMBA and three hormones in 7, 12 DMBA - induced rat mammary cancer: Three hypotheses Med Hypotheses 1982, 9:489-507 10.1016/0306-9877(82)90018-4 6818439
5. Russo IH Russo J Mammary gland neoplasia in long term rodent studies Environ Health Perspet 1996, 104:938-967 10.2307/3433143
6. Nandi S Guzman RC Yang J Hormones and mammary carcinogenesis in mice, rats and humans: A unifying hypothesis Proc Natl Acad Sci USA 1995, 92:3650-3657 42019 7731959 10.1073/pnas.92.9.3650
7. Mershon J Sall W Mitchner N Ben-Jonathan N Prolactin is a local growth factor in rat mammary tumors Endocrinology 1995, 136:3619-3623 10.1210/ en.136.8.3619 7628401
8. Kelly PA Dijane J Postel-Vinay MC Edery M The prolactin growth hormone receptor family Endocr Rev 1991, 12:235-251 1935820
9. Schroeder MD Symowicz J Schuler LA Prolactin modulates cell cycle regulators in mammary tumor epithelial cells Mol Endocrinol 2002, 16:45-57 10.1210/me.16.1.45 11773438
10. Vonderhaar BR Prolactin involvement in breast cancer Endocrine-Related Cancer 1999, 6:389-404 10.1677/erc.0.0060389 10516853
11. Schally AV Comaru-Schally AM Nagy A Kovacs M Szepeshazi K Plonowski A Varga JL Halmos G Hypothalamic hormones and cancer Front Neuroendocrinol 2001, 22:248-291 10.1006/frne.2001.0217 11587553
12. Watanabe N Niitsu Y Neda H Sone H Yamauchi N Umetsu T Urushizaki I Antitumor effect of tumor necrosis factor against various primarily cultured human cancer cells Jpn J Cancer Res 1985, 76(11):1115-1119 3936830
13. Watanabe N Niitsu Y Umeno H Kuriyama H Neda H Yamauchi N Maeda M Urushizaki I Toxic effect of tumor necrosis factor on tumor vasculature in mice Cancer Res 1988, 48:2179-2183 3349488
14. Weeler DL Ness KJ Oberley TD Verma AK Protein kinase C epsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice Cancer Res 2003, 63:6547-6555 14559850
15. Srivastava S Weitzmann MN Cenci S Ross FP Adler S Pacifici R Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD J Clin Invest 1999, 104:503-513 481048 10449442
16. Radisavljevic Z Nitric oxide suppression triggers apoptosis through the FKHRL1 (FOXO 3A)/ROK kinase pathway in human breast carcinoma cells Cancer 2003, 97:1358-1363 10.1002/cncr.10081 12599246
17. Dhar A Brindley JM Stark C Citro ML Keefer LK Colburn NH Nitric Oxide does not mediate but inhibits transformation and tumor phenotype. Mol Cancer Ther 2003, 2:1285-1293 14707269
18. Wink DA Miranda KM Espey MG Pluta RM Hewett SJ Colton C Vitek M Feelisch M Grisham MB Mechanism of the oxidant effects of nitric oxide Antioxid Redox Signal 2001, 3:203-213 10.1089/152308601300185179 11396476
19. Lala PK Chakraborty C Role of nitric oxide in carcinogenesis and tumour progression Lancet Oncol 2001, 2(3):149-156 10.1016/ S1470-2045(00)00256-4 11902565
20. Navarro Gonzálvez JA García Benayas C Arenas J Semiautomated measurement of nitrate in biological fluids Clin Chem 1998, 44(3):679-681 9510886
21. Hedley DW Friedlander ML Taylor IW Rugg CA Musgrove EA Method for analysis of cellular DNA content of paraffin-embedded pathological material being flow cytometry J Histochem Cytochem 1983, 31:1333-1335 6619538
22. McLemore DD el Naggar A Stephens LC Jardine JH Modified methodology to improve flow cytometric DNA histograms from paraffin-embedded material Stain Technol 1990, 65(6):279-291 2080523
23. Chan MM Lu X Merchant FM Iglehart JD Miron P Gene expression profiling of NMU-induced rat mammary tumors: Cross species comparison with human breast cancer Carcinogenesis 2005, 26:1343-1353 10.1093/carcin/bgi100 15845649
24. Ahlers I Solar P Buresova A Ahlersova E Very low sensitivity of Wistar: Han female rats to chemocarcinogen in mammary carcinogenesis induction Neoplasma 1998, 45:373-376 10210111
25. Guzman RC Osborn RC Swanson SM Sakthivel R Hwang SI Miyamoto S Nandi S Incidence of c-Ki-ras activation in N-methyl-N-nitrosourea-induced mammary carcinomas in pituitary-isografted mice Cancer Res 1992, 52:5732-5737 1394197
26. Manni A Raineri J Arafah BM Finegan HM Pearson OH Role of estrogen and prolactin in the growth and receptor levels of N-nitroso-methylurea - induced rat mammary tumours Cancer Res 1982, 42:3492-3495 6286107
27. Welsch CW Nagasawa H Prolactin and murine mammary tumorigenesis: A review Cancer Res 1977, 37(4):951-963 191183
28. Shaw-Bruha CM Pirrucello SJ Shull JD Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: promoter usage and alternative mRNA splicing Breast Cancer Res Treat 1997, 44:243-253 10.1023/A:1005879103367 9266104
29. Rycyzyn MA Clevenger CV The intranuclear prolactin/Cyclophilin B complex as a transcriptional inducer Proc Natl Acad Sci USA 2002, 99:6790-6795 124481 11997457 10.1073/pnas.092160699
30. Stalldecker GB Pigni J Fuentes AM Vegh I Prolactin response to dopamine and valproate administration in breast cancer patients Biomed Pharmacother 1989, 43:301-306 10.1016/0753-3322(89)90012-7 2506942
31. Clevenger CV Furth PA Hankinson SE Schuler LA The role of prolactin in mammary carcinoma Endocr Rev 2003, 24:1-27 1698952 12588805 10.1210/ er.2001-0036
32. Gutzman JH Rugowski DE Schroeder MD Watters JJ Schuler LA Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells Mol Endocrinol 2004, 18:3064-3075 1634796 15319452 10.1210/me.2004-0187
33. Glikman P Vegh I Pollina MA Mosto AH Levy CM Ornithine decarboxylase activity, prolactin blood levels, and estradiol and progesterone receptors in human breast cancer Cancer 1987, 60:2237-2243 10.1002/ 1097-0142(19871101)60:9<2237::AID-CNCR2820600923>3.0.CO;2-J 3440234
34. Rubio MA Torres-Aleman I Calle JR Cabranes JA Schally AV Charro AL D-Trp6-luteinizing hormone-realising hormone inhibits Sulpiride-induced hyperprolactinemia in normal men J Clin Endocr Metab 1987, 65:368-369 2954994
35. Tomita K Hosaka Y Aso Y Akasa H Shirai T Histological and flow cytometric analyses of carcinogenesis of rat prostate cancer Nippon Hinyokika Gakkai Zasshi 1990, 81:1396-1403 2232432
36. Monakhov AS Iakovleva TK Anisimov VN [Chromosomal damage in peripheral blood lymphocytes of rats in nitrosomethylurea-induced carcinogenesis] Eksp Onkol 1990, 12(6):40-43 [Article in Russian] 2261876
37. Schally AV Halmos G Rekasi Z Arencibia JM The actions of LH-RH agonists, antagonists and cytotoxic analogs on the LH-RH receptors on the pituitary and tumors Infertility and Reproductive Medicine Clinics of North America Philadelphia: Saunders Devroey P 2001:17-44
38. Tagami K Niwa K Lian Z Gao J Mori H Tamaya T Preventive effect of Juren-taiho-to on endometrial carcinogenesis in mice is based on Shimotsu-to constituent Bio Pharm Bull 2004, 27:156-161 10.1248/ bpb.27.156